These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 16507855)
1. The effect of tiotropium on exacerbations and airflow in patients with COPD. Dusser D; Bravo ML; Iacono P Eur Respir J; 2006 Mar; 27(3):547-55. PubMed ID: 16507855 [TBL] [Abstract][Full Text] [Related]
2. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N; Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease. Tang Y; Massey D; Zhong NS Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149 [TBL] [Abstract][Full Text] [Related]
4. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Powrie DJ; Wilkinson TM; Donaldson GC; Jones P; Scrine K; Viel K; Kesten S; Wedzicha JA Eur Respir J; 2007 Sep; 30(3):472-8. PubMed ID: 17504798 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the once-daily anticholinergic BEA2180 compared with tiotropium in patients with COPD. Abrahams R; Moroni-Zentgraf P; Ramsdell J; Schmidt H; Joseph E; Karpel J Respir Med; 2013 Jun; 107(6):854-62. PubMed ID: 23490224 [TBL] [Abstract][Full Text] [Related]
6. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease. Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G Respiration; 2006; 73(4):420-7. PubMed ID: 16484769 [TBL] [Abstract][Full Text] [Related]
7. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M; N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213 [TBL] [Abstract][Full Text] [Related]
8. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Troosters T; Celli B; Lystig T; Kesten S; Mehra S; Tashkin DP; Decramer M; Eur Respir J; 2010 Jul; 36(1):65-73. PubMed ID: 20185426 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Fukuchi Y; Fernandez L; Kuo HP; Mahayiddin A; Celli B; Decramer M; Kesten S; Liu D; Tashkin D Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680 [TBL] [Abstract][Full Text] [Related]
10. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
11. Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease. Covelli H; Bhattacharya S; Cassino C; Conoscenti C; Kesten S Pharmacotherapy; 2005 Dec; 25(12):1708-18. PubMed ID: 16305289 [TBL] [Abstract][Full Text] [Related]
12. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131 [TBL] [Abstract][Full Text] [Related]
13. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
14. [A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease]. Yin KS; Zhang DP; Shi Y; Sun LH; Min R; Xiao YL; Xia XR; Tan Y; Fu WZ Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):519-23. PubMed ID: 20979799 [TBL] [Abstract][Full Text] [Related]
15. A randomised, placebo-controlled, dose-finding study of AZD9668, an oral inhibitor of neutrophil elastase, in patients with chronic obstructive pulmonary disease treated with tiotropium. Vogelmeier C; Aquino TO; O'Brien CD; Perrett J; Gunawardena KA COPD; 2012 Apr; 9(2):111-20. PubMed ID: 22458939 [TBL] [Abstract][Full Text] [Related]
16. A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium. Anzueto A; Niewoehner DE; Leimer I; Rühmkorf F; Celli BR; Decramer M; Tashkin DP Respir Med; 2013 Dec; 107(12):1912-22. PubMed ID: 23969305 [TBL] [Abstract][Full Text] [Related]
17. Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial. Rabe KF; Fabbri LM; Israel E; Kögler H; Riemann K; Schmidt H; Glaab T; Vogelmeier CF Lancet Respir Med; 2014 Jan; 2(1):44-53. PubMed ID: 24461901 [TBL] [Abstract][Full Text] [Related]
18. [Early treatment of COPD with tiotropium]. Buhl R; Welte T; Vogelmeier C; Gillissen A; Voshaar T; Kögler H; Liu D; Glaab T Pneumologie; 2012 Oct; 66(10):589-95. PubMed ID: 23011771 [TBL] [Abstract][Full Text] [Related]
19. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM; N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765 [TBL] [Abstract][Full Text] [Related]
20. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Donohue JF; Fogarty C; Lötvall J; Mahler DA; Worth H; Yorgancioglu A; Iqbal A; Swales J; Owen R; Higgins M; Kramer B; Am J Respir Crit Care Med; 2010 Jul; 182(2):155-62. PubMed ID: 20463178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]